Molecular Grading of Urothelial Cell Carcinoma With Fibroblast Growth Factor Receptor 3 and MIB-1 is Superior to Pathologic Grade for the Prediction of Clinical OutcomeBas W.G. van Rhijn, Ellen C. Zwarthoff, André N. Vis et al.|Journal of Clinical Oncology|2003Cited by 321
The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate.Bas W.G. van Rhijn, Ellen C. Zwarthoff, Irene Lurkin et al.|PubMed|2001Cited by 309
Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder CancerBas W.G. van Rhijn, Theodorus van der Kwast, André N. Vis et al.|European Urology|2010Cited by 193
Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disordersBas W.G. van Rhijn, François Radvanyi, Angela A.G. van Tilborg et al.|European Journal of Human Genetics|2002Cited by 150
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†Bas W.G. van Rhijn, Tahlita C.M. Zuiverloon, Laura S. Mertens et al.|European Urology|2020Cited by 89